Shareholders of regeneron pharmaceuticals, inc. should contact the gross law firm before march 10, 2025 to discuss your rights - regn

New york , feb. 3, 2025 /prnewswire/ -- the gross law firm issues the following notice to shareholders of regeneron pharmaceuticals, inc. (nasdaq: regn). shareholders who purchased shares of regn during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

REGN Ratings Summary

REGN Quant Ranking